Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_assertion wasGeneratedBy ECO_0000203 NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_assertion wasDerivedFrom befree-2016 NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_assertion SIO_000772 24468836 NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_assertion evidence source_evidence_literature NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
- NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.